Brief: Everest Medicines Announces A Multi-Year Research And Develop Collaboration Agreement
23/09/2021 02:42
Sept 23 (Reuters) - Everest Medicines Ltd 1952.HK :
* CO & ABCELLERA BIOLOGICS ENTERED A MULTI-YEAR RESEARCH AND
DEVELOP COLLABORATION AGREEMENT
* AGREEMENT TO DISCOVER THERAPEUTIC ANTIBODIES FOR UP TO 10
TARGETS SELECTED BY CO
Further company coverage: 1952.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Everest Medicines
See all newsBrief: Everest Medicines Says NMPA Approves Cardamyst (Etripamil) NDA For PSVT In Adults In China
Brief: Everest Medicines Enters Commercialization Collaboration With Hainan Herui Pharmaceutical
Brief: Everest Medicines Says CBC Group Purchases 712,000 Everest Medicines Shares For Hk$19.2 Million From 16 To 17 June
Australia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region